Cargando…
Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
Metformin (MET) can effectively treat endometrial hyperplasia (EH), and the expression of glucose transporter type 4 insulin-responsive (GLUT4) is closely associated with the development of EH. The present study aimed to verify the effect of MET in functional EH and polycystic ovary syndrome (PCOS)....
Autores principales: | Liu, Jie, Zhao, Yangchun, Chen, Long, Li, Ruilan, Ning, Yumei, Zhu, Xiuzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175273/ https://www.ncbi.nlm.nih.gov/pubmed/35552758 http://dx.doi.org/10.3892/mmr.2022.12734 |
Ejemplares similares
-
Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020) -
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
por: Cannistraci, A., et al.
Publicado: (2022) -
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008) -
miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy
por: Wang, Weiwei, et al.
Publicado: (2021) -
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)